Recent news
October 2011
FDA releases plan to promote biomedical innovation
October 6, 2011 -- This week, the US Food and Drug Administration (FDA) unveiled a new plan to spur biomedical action. FDA Commissioner Margaret Hamburg announced that the plan—called “Driving Biomedical Innovation: Initiatives for Improving Products for Patients”—addresses the changing scientific landscape and will help alleviate concerns about the medical product development pipeline slowing down.
“America is at an important crossroads, where the science before us presents unprecedented opportunities to create new and better medical products and to promote better health for the public,” Hamburg said in a press release.
According to the official release from the FDA, the plan will focus on implementingthe following initiatives:
•Rebuilding FDA’s small business outreach services
•Building infrastructure to drive and support personalized medicine
•Creating a rapid drug development pathway for important targeted therapies
•Improving consistency and clarity in the medical device review process
•Training the next generation of innovators
•Streamlining and reforming FDA regulations
- Read the official press release from the FDA here.
- Read the full report from the FDA here.
- Read about other recent changes at the FDA that demonstrate its commitment to global health here.
